Chengdu Bright Eye Hospital Co. Ltd. (301239) — Capital Reinvestment Ratio

Latest as of December 2025: 0.42x

Chengdu Bright Eye Hospital Co. Ltd. (301239) has a Capital Reinvestment Ratio of 0.42x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥544.86 Million) in capital expenditures (CN¥226.41 Million). See free cash flow generation of Chengdu Bright Eye Hospital Co. Ltd. to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.42x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥544.86 Million
CNY

Capital Expenditures

CN¥226.41 Million
CNY

Data as of

Dec 2025
Most recent filing

Chengdu Bright Eye Hospital Co. Ltd. Capital Reinvestment Ratio (2019–2025)

This chart tracks Chengdu Bright Eye Hospital Co. Ltd.'s Capital Reinvestment Ratio across 7 annual periods.

Annual Capital Reinvestment Ratio for Chengdu Bright Eye Hospital Co. Ltd. (2019–2025)

Year-by-year Capital Reinvestment Ratio for Chengdu Bright Eye Hospital Co. Ltd. from 2019 to 2025. For live market cap and broader valuation context, see 301239 market cap.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.42x CN¥544.86 Million CN¥226.41 Million ▼ -70.7%
2024 1.42x CN¥382.43 Million CN¥542.86 Million ▲ +39.1%
2023 1.02x CN¥614.46 Million CN¥626.87 Million ▼ -0.7%
2022 1.03x CN¥319.30 Million CN¥327.99 Million ▲ +44.9%
2021 0.71x CN¥359.42 Million CN¥254.80 Million ▲ +10.0%
2020 0.64x CN¥227.51 Million CN¥146.60 Million ▼ -72.5%
2019 2.35x CN¥104.83 Million CN¥245.97 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow